PMC:7247521 / 60-955
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
3 | 161-169 | Disease | denotes | COVID-19 | MESH:C000657245 |
5 | 296-305 | Species | denotes | 2019-nCov | Tax:2697049 |
7 | 368-376 | Disease | denotes | COVID-19 | MESH:C000657245 |
33 | 803-817 | Gene | denotes | oxidoreductase | Gene:8630 |
35 | 751-754 | Chemical | denotes | FUs | |
36 | 828-833 | Chemical | denotes | lipid | MESH:D008055 |
39 | 484-492 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T2 | 11-16 | NCBITaxon:10239 | denotes | viral |
T3 | 49-58 | GO:0008152 | denotes | metabolic |
T4 | 161-169 | SP_7 | denotes | COVID-19 |
T5 | 179-184 | NCBITaxon:10239 | denotes | viral |
T6 | 190-203 | CHEBI:67079;CHEBI:67079 | denotes | -inflammatory |
T7 | 208-217 | GO:0008152 | denotes | metabolic |
T8 | 296-305 | SP_7 | denotes | 2019-nCov |
T9 | 368-376 | SP_7 | denotes | COVID-19 |
T16 | 484-492 | SP_7 | denotes | COVID-19 |
T17 | 523-532 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
T18 | 828-833 | CHEBI:18059;CHEBI:18059;GO:0006629 | denotes | lipid |
T19 | 834-851 | GO:0006629 | denotes | metabolic process |
T20 | 853-872 | GO:0042592 | denotes | homeostatic process |
T25522 | 11-16 | NCBITaxon:10239 | denotes | viral |
T26726 | 49-58 | GO:0008152 | denotes | metabolic |
T22563 | 161-169 | SP_7 | denotes | COVID-19 |
T45473 | 179-184 | NCBITaxon:10239 | denotes | viral |
T92290 | 190-203 | CHEBI:67079;CHEBI:67079 | denotes | -inflammatory |
T26450 | 208-217 | GO:0008152 | denotes | metabolic |
T9512 | 296-305 | SP_7 | denotes | 2019-nCov |
T7610 | 368-376 | SP_7 | denotes | COVID-19 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T1 | 828-833 | Body_part | denotes | lipid | http://purl.org/sig/ont/fma/fma67264 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T3 | 161-169 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T4 | 368-376 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T5 | 484-492 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 36-44 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T2 | 106-107 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T3 | 420-421 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T4 | 454-457 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T5 | 516-522 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | active |
T6 | 818-826 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1 | 696-704 | Chemical | denotes | medicine | http://purl.obolibrary.org/obo/CHEBI_23888 |
T2 | 828-833 | Chemical | denotes | lipid | http://purl.obolibrary.org/obo/CHEBI_18059 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 818-851 | http://purl.obolibrary.org/obo/GO_0045834 | denotes | activity, lipid metabolic process |
T2 | 828-851 | http://purl.obolibrary.org/obo/GO_0006629 | denotes | lipid metabolic process |
T3 | 834-851 | http://purl.obolibrary.org/obo/GO_0008152 | denotes | metabolic process |
T4 | 853-872 | http://purl.obolibrary.org/obo/GO_0042592 | denotes | homeostatic process |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T2 | 72-90 | Sentence | denotes | Graphical abstract |
T3 | 92-102 | Sentence | denotes | Highlights |
T4 | 103-145 | Sentence | denotes | • A novel FUNP analysis on QFPD function. |
T5 | 146-230 | Sentence | denotes | • QFPD act on COVID-19 via anti-viral, anti-inflammatory and metabolic programming. |
T6 | 231-306 | Sentence | denotes | • 9 QFPD ingredients presented good molecular docking score for 2019-nCov. |
T7 | 307-377 | Sentence | denotes | • SGMH, MXSG and Others are the top 3 efficient formula for COVID-19. |
T8 | 379-387 | Sentence | denotes | Abstract |
T9 | 388-502 | Sentence | denotes | Qingfei Paidu decoction (QFPD), a multi-component herbal formula, has been widely used to treat COVID-19 in China. |
T10 | 503-576 | Sentence | denotes | However, its active compounds and mechanisms of action are still unknown. |
T11 | 577-705 | Sentence | denotes | Firstly, we divided QFPD into five functional units (FUs) according to the compatibility theory of traditional Chinese medicine. |